The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© Thomson Reuters 2020.As globe gallops into vaccine trials, insurers remain unfazed
By Noor Zainab Hussain, Carolyn Cohn and Ludwig Burger LONDON/FRANKFURT©2024 GPlusMedia Inc.
2 Comments
Login to comment
Yrral
The US do not even have the infrastructure to distribute the vaccine, the money has not been approved nor the distribution or needed storage
kurisupisu
How about not having the hapless individuals, contributing their health, not sign a waiver?
If side effects are so ‘rare’ what is the problem?
“scientific integrity” does not mean acceptance of liability, does it?
Pharmaceutical companies make huge profits from people putting their health at risk in clinical trials yet always seek to limit responsibility.
The profits from a successful safe vaccine against Covid-19 will be phenomenal!
Something is not right!